Tue, Sep 23, 2014, 11:14 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

PLC Systems Inc. Message Board

  • scodeb99 scodeb99 Dec 12, 2011 6:13 PM Flag

    US trial

    It looks like the Phase 3 trial has or almost has started.
    On the clinical trials gov website the record for this trial was updated on Friday. Study start date was changed to December 2011 and the status of the trial was changed from "not yet recruiting" to "Active, not recruiting".
    That update was from Friday.

    If you go to the Northwestern Memorial Hospital website and check the clinical trials they are participating in they have the Renalguard trial listed under trials that are currently recruiting patients.

    So if this thing hasn't started it sounds darn close.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • i gave u a 5 star rating and logged in to do so and said it was not permitted ? cgcp told who finance them but yet who financed plc remains a mystery ? plc alway's said they thought there heart laser was superior to cgcp yet cgcp got bought out at a much higher price.............just imo. seem's like a inside job to to rob share holders and if not not plc disclose who loan plc the money.............renal guard imo. is a gold mine with lot's of gold

      • 1 Reply to scomasea
      • It is something when you read Cryolife's statements on what they believe the potential still is for TMR and the uses for the laser. It does make you wonder why PLC wasn't able to do better in that regard.

        I do agree with you though that Renalguard is a goldmine and that this product looks to be a real winner that should restore the value to PLC. I am looking forward to the 4th quarter sales numbers.

 
PLCSF
0.00510.0000(0.00%)Sep 23 2:36 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.